Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 years of age or older.~2. Serum PSA between 4 and 10 ng/mL.~3. A diagnosis of prostate cancer based on extended (twelve core) random prostate biopsy within three months prior to study entry.~4. Clinically localized prostate carcinoma i.e. TNM stage T2c or less.~5. The patient has elected to undergo radical prostatectomy to treat the prostate carcinoma.~6. The patient consents to undergo a diagnostic transrectal ultrasound of the prostate with elastography.~Exclusion Criteria:~1. Any contraindication to transrectal ultrasonography, including prior anorectal surgery, inflammatory bowel disease, rectal fistula, or fissure-in-ano.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sonoelastography (Type: EXPERIMENTAL): Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.

Based on this trial design, predict the completion outcome and termination type (if applicable).